Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FEVERTREE DRINKS PLC Regulatory Filings 2018

Oct 31, 2018

7637_rns_2018-10-31_000d78ba-53f8-4e87-9486-1417ad3d0993.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7836F

Fevertree Drinks PLC

31 October 2018

31 October 2018

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Appointment of Nomad and Joint Broker

Fever-Tree, the world's leading supplier of premium carbonated mixers, announces the appointment of Numis Securities Limited as the Company's Nomad and Joint Broker with immediate effect.

Ends

For further information:

Fevertree Drinks plc

Tim Warrillow, Co-founder and CEO

Andy Branchflower, Finance Director

Oliver Winters, Communications & IR Director
+44 (0)20 7349 4922
FTI Consulting - Financial PR

Jonathon Brill

Tom Hufton

Fiona Walker
+44 (0)20 3727 1000

[email protected]
Numis Securities - Nominated Adviser and Joint Broker

Alex Ham / Matt Lewis

Oliver Cardigan / Hugo Rubinstein

Investec Bank plc - Joint Broker

David Flin

Alex Wright

David Anderson
+44 (0)20 7260 1000

+44 (0)20 7597 5970

Notes to Editors:

Fever-Tree is the world's leading supplier of premium carbonated mixers for alcoholic spirits by retail sales value, with distribution to over 70 countries worldwide. Based in the UK, the brand was launched in 2005 to provide high quality mixers which could cater to the growing demand for premium spirits, in particular gin, but also increasingly for vodka, rum and whisky. The Company now sells a range of carbonated mixers to hotels, restaurants, bars and cafes ("On Trade") as well as selected retail outlets ("Off Trade").

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

APPWGGGAUUPRPUU